Morningside Venture Investments Ltd, 10% Owner at Apellis Pharmaceuticals, Inc. (APLS), bought 540,540 shares at $37.00 ($20.0M) on 2020-01-13, disclosed to the SEC on 2020-01-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| AMLX | SELL | 2023-03-29 | $4.9M | — | Filing → |
| AMLX | SELL | 2023-03-23 | $4.0M | — | Filing → |
| AMLX | SELL | 2023-03-17 | $594K | — | Filing → |